Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.

相似書籍

• Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
  由: Pasanen, P. A., et al.
  出版: (1992)
• A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
  由: Pasanen, P. A., et al.
  出版: (1994)
• CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
  由: Haglund, C., et al.
  出版: (1994)
• Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
  由: Kuusela, P., et al.
  出版: (1991)
• Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
  由: Haglund, C., et al.
  出版: (1989)